Literature DB >> 3781622

Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

S Kotani, H Takada, I Takahashi, T Ogawa, M Tsujimoto, H Shimauchi, T Ikeda, H Okamura, T Tamura, K Harada.   

Abstract

Synthetic lipid A analogs, beta(1-6)glucosamine disaccharide 1,4'-bisphosphates, which possesses four tetradecanoyl groups at the 2- and 2'-amino, and 3- and 3'-hydroxyl groups (LA-17-PP), and each two of the (R)-3-hydroxytetradecanoyl and tetradecanoyl groups at the 2- and 2'-amino and 3- and 3'-hydroxyl groups, respectively (LA-18-PP), were far less endotoxic than synthetic (506, LA-15-PP) and bacterial Escherichia coli type lipid A's; neither compound showed any detectable lethal toxicity in chicken embryos or preparatory activity for the local Shwartzman reaction in rabbits. Also both compounds were only weakly pyrogenic and comparably less lethally toxic in galactosamine-loaded mice than the reference synthetic and bacterial lipid A's and a synthetic counterpart to biosynthetic lipid A precursor Ia (406, LA-14-PP). Nevertheless, LA-17-PP and LA-18-PP exhibited definite in vivo immunoadjuvant activity in mice, and the ability to induce a possible tumor necrosis factor and alpha/beta interferon in Mycobacterium bovis BCG and Propionibacterium acnes-primed mice, respectively, although these activities were weaker than those of the reference lipid A's. 4'-Monophosphate analogs of the above two test compounds exhibited neither endotoxic nor beneficial activities, but they showed remarkable in vitro bioactivities comparable to those of the corresponding bisphosphate compounds; the ability to activate the human complement system and the clotting enzyme cascade of horseshoe crab amoebocyte lysate, stimulatory effects on guinea pig and murine peritoneal macrophages, and murine splenocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781622      PMCID: PMC260222          DOI: 10.1128/iai.54.3.673-682.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  OBSERVATIONS ON MODE OF ACTION OF ENDOTOXIN IN CHICK EMBRYOS.

Authors:  R A FINKELSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

3.  Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; K Harada; Y Mori; A Kawasaki; A Tanaka; S Nagao; S Tanaka
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  Lipid A and immunotherapy.

Authors:  E Ribi; J L Cantrell; K Takayama; N Qureshi; J Peterson; H O Ribi
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

5.  Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.

Authors:  S Kanegasaki; Y Kojima; M Matsuura; J Y Homma; A Yamamoto; Y Kumazawa; K Tanamoto; T Yasuda; T Tsumita; M Imoto
Journal:  Eur J Biochem       Date:  1984-09-03

6.  Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications.

Authors:  T Obayashi
Journal:  J Lab Clin Med       Date:  1984-09

7.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; E Ribi
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

9.  Separation and characterization of toxic and nontoxic forms of lipid A.

Authors:  K Takayama; N Qureshi; E Ribi; J L Cantrell
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

10.  High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes.

Authors:  H Okamura; K Kawaguchi; K Shoji; Y Kawade
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

View more
  8 in total

1.  Bacterial endotoxins: comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities.

Authors:  J Sourek; M Svobodová; R Dvorák; J Müller; K Sůla; K Nouza
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

2.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Dissociation of cell-associated interleukin-1 (IL-1) and IL-1 release induced by lipopolysaccharide and lipid A.

Authors:  J M Cavaillon; C Fitting; M Caroff; N Haeffner-Cavaillon
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 6.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

Review 7.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013

8.  Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.

Authors:  N L Kovach; E Yee; R S Munford; C R Raetz; J M Harlan
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.